Related Experiment Video
Updated: May 19, 2026
13:45
Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
Published on: December 23, 2010
[Modulation of leukotriene pathway - potential targets].
Hoffman Peter1, Bezáková Lýdia
1Univerzita Komenskeho v Bratislave, Katedra bukovej a molekularnej biologie, Bratislava, Slovenska Republika. hoffman@fpharm.uniba.sk
Summary
Leukotrienes (LT) are key lipid mediators in inflammation. Understanding the leukotriene pathway and its enzymes, aided by structural biology, accelerates the development of new anti-inflammatory, anti-atherosclerosis, and anti-cancer drugs.
Area of Science:
- Biochemistry
- Enzymology
- Signal Transduction
Context:
- Leukotrienes (LT) are potent lipid mediators involved in inflammatory signaling pathways.
- The leukotriene pathway, originating from arachidonic acid, is crucial in biological responses.
- Key enzymes include 5-lipoxygenase, 5-lipoxygenase activating protein, leukotriene A4-hydrolase, and leukotriene C4-synthase.
Purpose:
- To explore the enzymatic mechanisms of the leukotriene pathway.
- To highlight the impact of recent advancements in X-ray structural analysis of leukotriene pathway enzymes.
- To identify therapeutic targets for modulating inflammatory processes.
Summary:
- The leukotriene pathway involves a series of enzymatic transformations of arachidonic acid.
- 5-lipoxygenase, in complex with 5-lipoxygenase activating protein, initiates the pathway by forming 5-hydroperoxyeicosatetraenoic acid.
- Subsequent steps involve leukotriene A4-hydrolase and leukotriene C4-synthase, leading to various leukotriene products.
Impact:
- Advances in understanding the 3D structures of biocatalysts, particularly their active sites, have accelerated drug development.
- The complex, enzymatically controlled leukotriene pathway offers multiple targets for therapeutic intervention.
- This research opens new avenues for treating inflammatory diseases, atherosclerosis, and cancer.
More Related Videos
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:26Acute Inflammation II: Cellular Phase
The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...